VERA · Vera Therapeutics, Inc. · Documents
Market Cap
$2.47B
Shares
72.06M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 10-Q | 2026-08-10 | 2026-06-30 | |
| 8-K | 2026-08-10 | — | |
| 8-K | 2026-07-09 | — | |
| 8-K | 2026-07-07 | — | |
| 8-K | 2026-06-02 | — | |
| 8-K | 2026-05-26 | 2026-05-21 | |
| 10-Q | 2026-05-07 | 2026-03-31 | |
| 8-K | 2026-05-07 | — | |
| DEF 14A | 2026-04-09 | 2026-05-21 | |
| 8-K | 2026-03-09 | 2026-03-05 | |
| 8-K | 2026-02-26 | — | |
| 10-K | 2026-02-26 | 2025-12-31 | |
| 8-K | 2025-12-18 | 2025-12-16 | |
| 8-K | 2025-12-10 | 2025-12-09 | |
| 8-K | 2025-11-26 | 2025-11-25 | |
| 8-K | 2025-11-06 | — | |
| 8-K | 2025-11-05 | — | |
| 10-Q | 2025-11-05 | 2025-09-30 | |
| 10-Q | 2025-08-05 | 2025-06-30 | |
| 8-K | 2025-08-05 | — | |
| 8-K | 2025-08-05 | — | |
| 8-K | 2025-06-03 | 2025-06-02 | |
| 8-K | 2025-06-02 | — | |
| 8-K | 2025-05-19 | 2025-05-14 | |
| 10-Q | 2025-05-07 | 2025-03-31 | |
| 8-K | 2025-05-06 | — | |
| DEF 14A | 2025-04-03 | 2025-05-14 | |
| 10-K | 2025-02-28 | 2024-12-31 | |
| 8-K | 2025-02-26 | — | |
| 8-K | 2025-01-13 | — | |
| 8-K | 2024-11-07 | — | |
| 10-Q | 2024-11-07 | 2024-09-30 | |
| 8-K | 2024-10-31 | 2024-10-29 | |
| 8-K | 2024-10-28 | 2024-10-26 | |
| 8-K | 2024-10-02 | — | |
| 8-K | 2024-08-08 | — | |
| 10-Q | 2024-08-08 | 2024-06-30 | |
| 8-K | 2024-07-02 | 2024-06-26 | |
| 8-K | 2024-06-12 | 2024-06-07 | |
| 8-K | 2024-05-17 | 2024-05-15 | |
| 10-Q | 2024-05-10 | 2024-03-31 | |
| 8-K | 2024-05-09 | — | |
| DEF 14A | 2024-04-03 | 2024-05-15 | |
| 10-K | 2024-03-27 | 2023-12-31 | |
| 8-K | 2024-03-20 | — | |
| 8-K | 2024-01-30 | 2024-01-29 | |
| 8-K | 2024-01-29 | — | |
| 8-K | 2024-01-25 | — | |
| 8-K | 2024-01-08 | 2024-01-03 | |
| 8-K | 2024-01-08 | — |
Showing 1–50 of 89 filings
Key facts
CIK
1831828
CUSIP
92337R101
13F (30d)
132 filings
132 filers
Visit website
Investor relations